Kyntra Bio, Inc.
KYNB
$6.82
-$0.19-2.71%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.22M | 200.64M | -7.60M | 4.64M | 17.98M |
| Total Depreciation and Amortization | 8.00K | 192.00K | 221.00K | 327.00K | 352.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 726.00K | -42.35M | 2.27M | 3.41M | -1.02M |
| Change in Net Operating Assets | -4.84M | -160.33M | 17.79M | -5.65M | -47.78M |
| Cash from Operations | -18.33M | -1.85M | 12.68M | 2.72M | -30.47M |
| Capital Expenditure | 0.00 | -9.00K | -13.00K | -16.00K | -141.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 206.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 6.41M | 90.20M | -- | -- | -- |
| Other Investing Activities | -58.12M | -3.04M | -- | -- | 1.66M |
| Cash from Investing | -51.71M | 87.16M | -13.00K | -16.00K | 1.72M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.00K | -80.55M | 3.00K | -5.00K | -4.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 23.00K |
| Repurchase of Common Stock | -8.00K | -12.00K | -12.00K | -37.00K | -14.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -5.35M | 0.00 | -46.00K | -- |
| Cash from Financing | -14.00K | -85.92M | -9.00K | -88.00K | 5.00K |
| Foreign Exchange rate Adjustments | -49.00K | -1.26M | 981.00K | 1.41M | -87.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.10M | -1.87M | 13.64M | 4.02M | -28.83M |